Guinea-Bissau vs Senegal: Antiretroviral therapy coverage
Guinea-Bissau
79.0%
in 2024
Senegal
79.0%
in 2024
Guinea-Bissau rank
53rd
Senegal rank
53rd
Antiretroviral therapy coverage over time
- Guinea-Bissau
- Senegal
How they compare
Guinea-Bissau currently reports 79.0% against 79.0% in Senegal, a difference of 0.0%.
Across all 25 years both countries report, Senegal has been ahead every year.
Guinea-Bissau ranks 53rd and Senegal ranks 53rd of 143 countries.
Senegal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.6% | 6.5% | 4.9% | Senegal |
| 2010s | 26.0% | 45.5% | 19.5% | Senegal |
| 2020s | 63.2% | 76.2% | 13.0% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Guinea-Bissau or Senegal?
- Guinea-Bissau, at 79.0% against 79.0% in Senegal as of 2024.
- What is the difference in antiretroviral therapy coverage between Guinea-Bissau and Senegal?
- 0.0%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Senegal?
- 25 years are reported by both, from 2000 to 2024.
- How do Guinea-Bissau and Senegal rank globally for antiretroviral therapy coverage?
- Guinea-Bissau ranks 53rd and Senegal ranks 53rd of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.